Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk

ObjectivePost-myocardial infarction (MI) care is crucial to preventing recurrent major adverse cardiovascular events (MACE), but can be complicated to personalise. A tool is needed that effectively stratifies risk of cardiovascular (CV) events 1–3 years after MI but is also clinically usable.Methods...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open heart 2018, Vol.5 (1), p.e000723-e000723
Hauptverfasser: Horne, Benjamin D, Muhlestein, Joseph B, Bhandary, Durgesh, Hoetzer, Greta L, Khan, Naeem D, Bair, Tami L, Lappé, Donald L
Format: Artikel
Sprache:eng
Schlagworte:
Basic and Translational Research
Biomarkers
Blood tests
Cardiovascular disease
Clinical medicine
Coronary vessels
Empowerment
Heart attacks
Heart failure
Hospitals
Mens health
Mortality
Stroke
Womens health
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectivePost-myocardial infarction (MI) care is crucial to preventing recurrent major adverse cardiovascular events (MACE), but can be complicated to personalise. A tool is needed that effectively stratifies risk of cardiovascular (CV) events 1–3 years after MI but is also clinically usable.MethodsPatients surviving ≥1 year after an index MI with ≥1 risk factor for recurrent MI (ie, age ≥65 years, prior MI, multivessel coronary disease, diabetes, glomerular filtration rate
ISSN:2053-3624
2398-595X
2053-3624
DOI:10.1136/openhrt-2017-000723